Literature DB >> 10769818

Mechanisms of deep brain stimulation and future technical developments.

E B Montgomery1, K B Baker.   

Abstract

Possible mechanisms underlying the therapeutic effect of deep brain stimulation (DBS) are reviewed, particularly the notion that DBS is inhibitory. Computer simulations are described that model the effect of different frequencies and regularity of neuronal activity (target neuron), either spontaneous or stimulated, on information transfer between two other neurons. Most simulations resulted in a loss of information. These were the least with high frequency and regular activity or stimulation of the target neuron with regularity having the least deleterious effect on information transfer. The simulations suggest that irregular activity in neurons converging with other neurons can result in a loss of information transfer. This may explain why increased irregularity in globus pallidus activity associated with Parkinson's disease, dystonia and hemiballismus may result in symptoms. Further, the therapeutic effect of DBS may be due to driving neurons at higher and perhaps more importantly, regular frequencies. There were simulations in which information transfer was augmented suggesting the presence of stochastic resonance. This most often occurred with low frequency activity in the target neuron. It is hypothesized that low frequency activity, either spontaneous or stimulated, could account for involuntary movements, including tremor. Future directions and challenges to DBS are also discussed.

Entities:  

Mesh:

Year:  2000        PMID: 10769818     DOI: 10.1080/01616412.2000.11740668

Source DB:  PubMed          Journal:  Neurol Res        ISSN: 0161-6412            Impact factor:   2.448


  53 in total

Review 1.  Neuromodulation interventions for addictive disorders: challenges, promise, and roadmap for future research.

Authors:  Primavera A Spagnolo; David Goldman
Journal:  Brain       Date:  2017-05-01       Impact factor: 13.501

2.  Deep brain stimulation in Parkinson's disease.

Authors:  S J Groiss; L Wojtecki; M Südmeyer; A Schnitzler
Journal:  Ther Adv Neurol Disord       Date:  2009-11       Impact factor: 6.570

3.  Patient-specific analysis of the volume of tissue activated during deep brain stimulation.

Authors:  Christopher R Butson; Scott E Cooper; Jaimie M Henderson; Cameron C McIntyre
Journal:  Neuroimage       Date:  2006-11-17       Impact factor: 6.556

4.  Sources and effects of electrode impedance during deep brain stimulation.

Authors:  Christopher R Butson; Christopher B Maks; Cameron C McIntyre
Journal:  Clin Neurophysiol       Date:  2005-12-22       Impact factor: 3.708

5.  Restoring the basal ganglia in Parkinson's disease to normal via multi-input phase-shifted deep brain stimulation.

Authors:  Rahul Agarwal; Sridevi V Sarma
Journal:  Annu Int Conf IEEE Eng Med Biol Soc       Date:  2010

6.  Role of electrode design on the volume of tissue activated during deep brain stimulation.

Authors:  Christopher R Butson; Cameron C McIntyre
Journal:  J Neural Eng       Date:  2005-12-19       Impact factor: 5.379

7.  Neural correlates of STN DBS-induced cognitive variability in Parkinson disease.

Authors:  M C Campbell; M Karimi; P M Weaver; J Wu; D C Perantie; N A Golchin; S D Tabbal; J S Perlmutter; T Hershey
Journal:  Neuropsychologia       Date:  2008-07-19       Impact factor: 3.139

8.  Current steering to control the volume of tissue activated during deep brain stimulation.

Authors:  Christopher R Butson; Cameron C McIntyre
Journal:  Brain Stimul       Date:  2008-01       Impact factor: 8.955

9.  Deep brain stimulation activation volumes and their association with neurophysiological mapping and therapeutic outcomes.

Authors:  C B Maks; C R Butson; B L Walter; J L Vitek; C C McIntyre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-04-10       Impact factor: 10.154

Review 10.  Systems approaches to optimizing deep brain stimulation therapies in Parkinson's disease.

Authors:  Sabato Santaniello; John T Gale; Sridevi V Sarma
Journal:  Wiley Interdiscip Rev Syst Biol Med       Date:  2018-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.